NeueHealth, Inc.: debt financing — Bright Health secures $60M NEA credit facility at 15%, permanent waiver of default, warrants up to 1.66M shares at $0.01

to provide for a credit facility pursuant to which, among other things, the lenders have provided $60.0 million delayed draw term loan commitments.

On August 4, 2023, Bright Health Group, Inc. (the “Company”) entered into a Credit Agreement (as amended, supplemented, restated or otherwise modified from time to time, the “New Credit Agreement”), among the Company, NEA 18 Venture Growth Equity, L.P. ("NEA") and the lenders from time to time party thereto (together with NEA and each of their respective successors and assigns, the “Lenders”), to provide for a credit facility pursuant to which, among other things, the lenders have provided $60.0 million delayed draw term loan commitments.

On August 4, 2023, the Company entered into a third amended and restated limited waiver and consent (the “New Waiver”) under the Credit Agreement, dated as of March 1, 2021 (as amended by Amendment No. 1 dated as of August 2, 2021, Amendment No. 2 dated as of November 20, 2021, Amendment No. 3 dated as of November 8, 2022, Amendment No. 4 dated as of June 23, 2023 and as further amended, supplemented or otherwise modified from time to time prior to the date hereof, the “Existing Credit Agreement”), by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), and the lenders party thereto.